2024 Methods Summit Summary

This summary report captures insights from the 5th Annual IVI Methods Summit, which focused on the future of patient-centered health technology assessment (HTA).

Valuing Rare Disease Treatments in Healthcare: Real Experience, Real Impact

This report, developed by the Innovation and Value Initiative and the EveryLife Foundation for Rare Diseases, outlines how comparative effectiveness research, patient-centered outcomes research, and value assessment must evolve to better reflect what matters to people living with rare diseases and their caregivers.

Economic Impacts Framework Executive Summary

The Executive Summary presents a concise overview of a new Economic Impacts Framework designed to help researchers, funders, and decision-makers systematically identify and incorporate the full range of economic impacts that healthcare encounters impose on patients and caregivers—

Economic Impacts Framework Full Report

This report presents a consensus-based framework to help researchers, funders, and decision-makers systematically identify, define, and measure the full range of economic impacts that health conditions and healthcare encounters impose on patients and their caregivers—going beyond traditional direct medical costs.

Health Equity Initiative Overview

This overview describes IVI’s Health Equity Initiative, which aims to embed health equity as a core objective of value assessment and health technology assessment.